Cited by

• Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity.

  van Rensburg SJ, van Toorn R, Erasmus RT, Hattingh C, Johannes C, Moremi KE, Kemp MC, Engel-Hills P, Kotze MJ. van Rensburg SJ, et al. Metab Brain Dis. 2021 Aug;36(6):1151-1167. doi: 10.1007/s11011-021-00711-w. Epub 2021 Apr 28. Metab Brain Dis. 2021. PMID: 33909200 Review.
• The conundrum of iron in multiple sclerosis--time for an individualised approach.

  van Rensburg SJ, Kotze MJ, van Toorn R. van Rensburg SJ, et al. Metab Brain Dis. 2012 Sep;27(3):239-53. doi: 10.1007/s11011-012-9290-1. Epub 2012 Mar 17. Metab Brain Dis. 2012. PMID: 22422107 Free PMC article. Review.
• The fat mass and obesity-associated FTO rs9939609 polymorphism is associated with elevated homocysteine levels in patients with multiple sclerosis screened for vascular risk factors.

  Davis W, van Rensburg SJ, Cronje FJ, Whati L, Fisher LR, van der Merwe L, Geiger D, Hassan MS, Matsha T, Erasmus RT, Kotze MJ. Davis W, et al. Metab Brain Dis. 2014 Jun;29(2):409-19. doi: 10.1007/s11011-014-9486-7. Epub 2014 Feb 18. Metab Brain Dis. 2014. PMID: 24532085
• Quo vadis multiple sclerosis?

  Steiner I, Mosberg-Galili R. Steiner I, et al. Inflammopharmacology. 2010 Dec;18(6):261-2. doi: 10.1007/s10787-010-0067-z. Epub 2010 Nov 3. Inflammopharmacology. 2010. PMID: 21042863 No abstract available.
• Identification of an iron-responsive subtype in two children diagnosed with relapsing-remitting multiple sclerosis using whole exome sequencing.

  van Rensburg SJ, Peeters AV, van Toorn R, Schoeman J, Moremi KE, van Heerden CJ, Kotze MJ. van Rensburg SJ, et al. Mol Genet Metab Rep. 2019 Mar 23;19:100465. doi: 10.1016/j.ymgmr.2019.100465. eCollection 2019 Jun. Mol Genet Metab Rep. 2019. PMID: 30963028 Free PMC article.